1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Joseph Broderick: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interventional Management of Stroke (IMS) III Trial IV rt-PA alone, endovascular therapy - Stroke | Phase 3 | Terminated | Joseph Broderick | 656 | 2006-08-01 | 2013-12-13 |
Ischemic Stroke (1) · Stroke (1) · Thrombosis (1)
Tissue Plasminogen Activator (1)
Australia (1) · Canada (1) · France (1) · Germany (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United States (1)
Joseph P. Broderick, MD (1) · Thomas A. Tomsick, MD (1)
PMID 23390923, PMID 24335227, PMID 24473178, PMID 24699059, PMID 24815501, PMID 24876261, PMID 25342652, PMID 25791716, PMID 25858239, PMID 25953374, PMID 26138125, PMID 26486865, PMID 28336740, PMID 28468840, PMID 28483774, PMID 31795895, PMID 36169032, PMID 36599699
U01NS052220 (1), U01NS054630 (1)